questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Ureohydrolases
Ureohydrolases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ureohydrolases : Questions médicales les plus fréquentes",
"headline": "Ureohydrolases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ureohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-02",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ureohydrolases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hydrolases",
"url": "https://questionsmedicales.fr/mesh/D006867",
"about": {
"@type": "MedicalCondition",
"name": "Hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D006867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Arginase",
"alternateName": "Arginase",
"url": "https://questionsmedicales.fr/mesh/D001119",
"about": {
"@type": "MedicalCondition",
"name": "Arginase",
"code": {
"@type": "MedicalCode",
"code": "D001119",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.913.292"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Ureohydrolases",
"alternateName": "Ureohydrolases",
"code": {
"@type": "MedicalCode",
"code": "D014512",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "M Sinn",
"url": "https://questionsmedicales.fr/author/M%20Sinn",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany. malte.sinn@uni-konstanz.de."
}
},
{
"@type": "Person",
"name": "L Riede",
"url": "https://questionsmedicales.fr/author/L%20Riede",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "J R Fleming",
"url": "https://questionsmedicales.fr/author/J%20R%20Fleming",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "D Funck",
"url": "https://questionsmedicales.fr/author/D%20Funck",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "H Lutz",
"url": "https://questionsmedicales.fr/author/H%20Lutz",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Konstanz, Konstanz, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Patient satisfaction - results of cluster analysis of finnish patients.",
"datePublished": "2023-06-13",
"url": "https://questionsmedicales.fr/article/37312180",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-023-09625-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "RNAprofiling 2.0: Enhanced Cluster Analysis of Structural Ensembles.",
"datePublished": "2023-03-17",
"url": "https://questionsmedicales.fr/article/36933824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jmb.2023.168047"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analysis of the Intelligent Tourism Route Planning Scheme Based on the Cluster Analysis Algorithm.",
"datePublished": "2022-06-28",
"url": "https://questionsmedicales.fr/article/35800698",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/3310676"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analysis of Graphic Perception Education for Young Children Based on Fuzzy Clustering Analysis.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35774433",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/8046713"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparative Analysis of the Performance of Complex Texture Clustering Driven by Computational Intelligence Methods Using Multiple Clustering Models.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36210982",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/8449491"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Ureohydrolases",
"item": "https://questionsmedicales.fr/mesh/D014512"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ureohydrolases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ureohydrolases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ureohydrolases",
"description": "Comment diagnostiquer une déficience en ureohydrolases ?\nQuels tests sont utilisés pour évaluer l'activité des ureohydrolases ?\nQuels symptômes indiquent un problème avec les ureohydrolases ?\nLes tests génétiques sont-ils utiles pour les ureohydrolases ?\nComment l'historique médical aide-t-il au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Cluster+Analysis&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ureohydrolases",
"description": "Quels sont les symptômes d'une accumulation d'urée ?\nComment se manifeste une hyperammoniémie ?\nLes symptômes varient-ils selon l'âge ?\nQuels signes cliniques sont associés à une déficience en ureohydrolases ?\nPeut-on avoir des symptômes sans déficience enzymatique ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Cluster+Analysis&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ureohydrolases",
"description": "Peut-on prévenir les troubles liés aux ureohydrolases ?\nLes conseils diététiques peuvent-ils prévenir ces troubles ?\nLe dépistage néonatal est-il recommandé ?\nLes antécédents familiaux influencent-ils la prévention ?\nLes vaccinations ont-elles un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Cluster+Analysis&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ureohydrolases",
"description": "Quel est le traitement principal pour les troubles liés aux ureohydrolases ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nLa dialyse est-elle une option de traitement ?\nLes thérapies nutritionnelles sont-elles efficaces ?\nY a-t-il des traitements expérimentaux pour ces troubles ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Cluster+Analysis&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ureohydrolases",
"description": "Quelles complications peuvent survenir avec une hyperammoniémie ?\nLes troubles du comportement sont-ils une complication ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes complications peuvent-elles survenir à tout âge ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Cluster+Analysis&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ureohydrolases",
"description": "Quels sont les facteurs de risque pour les troubles des ureohydrolases ?\nL'alimentation joue-t-elle un rôle dans les facteurs de risque ?\nLes infections peuvent-elles aggraver les troubles ?\nLes facteurs environnementaux influencent-ils ces troubles ?\nLes médicaments peuvent-ils être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Cluster+Analysis&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en ureohydrolases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et urinaires mesurant les niveaux d'urée et d'ammoniac sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des ureohydrolases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques spécifiques et des analyses biochimiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les ureohydrolases ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la confusion, la fatigue et des troubles neurologiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les ureohydrolases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations génétiques liées à des déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Comment l'historique médical aide-t-il au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical peut révéler des antécédents familiaux de troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une accumulation d'urée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une hyperammoniémie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des troubles neurologiques, des céphalées et des convulsions."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus graves chez les nourrissons et les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une déficience en ureohydrolases ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'irritabilité, la léthargie et des troubles de l'alimentation peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans déficience enzymatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres conditions médicales peuvent provoquer des symptômes similaires."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux ureohydrolases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un dépistage précoce peut aider à gérer les risques."
}
},
{
"@type": "Question",
"name": "Les conseils diététiques peuvent-ils prévenir ces troubles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conseils diététiques peuvent réduire le risque d'accumulation d'urée."
}
},
{
"@type": "Question",
"name": "Le dépistage néonatal est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage néonatal peut identifier les troubles métaboliques précocement."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles peuvent justifier un suivi médical accru."
}
},
{
"@type": "Question",
"name": "Les vaccinations ont-elles un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccinations ne préviennent pas directement les troubles liés aux ureohydrolases."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les troubles liés aux ureohydrolases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est une restriction protéique et des suppléments d'arginine."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à gérer les symptômes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent être prescrits pour réduire les niveaux d'ammoniac."
}
},
{
"@type": "Question",
"name": "La dialyse est-elle une option de traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la dialyse peut être utilisée pour éliminer l'excès d'ammoniac dans les cas graves."
}
},
{
"@type": "Question",
"name": "Les thérapies nutritionnelles sont-elles efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une thérapie nutritionnelle adaptée peut aider à gérer les niveaux d'urée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour ces troubles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux, comme la thérapie génique, sont en cours d'étude."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une hyperammoniémie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications graves incluent des lésions cérébrales et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles du comportement sont-ils une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles du comportement peuvent survenir en raison de l'accumulation d'ammoniac."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent gravement affecter la qualité de vie et nécessiter des soins constants."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles survenir à tout âge ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent survenir à tout âge, mais sont plus fréquentes chez les jeunes."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles des ureohydrolases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et des régimes inappropriés."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans les facteurs de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en protéines peut augmenter le risque d'accumulation d'urée."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver les troubles ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes et augmenter les niveaux d'ammoniac."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils ces troubles ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux comme la pollution peuvent affecter le métabolisme."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent interférer avec le métabolisme de l'urée et des enzymes."
}
}
]
}
]
}
Healthcare providers must understand patients' expectations and perceptions of the care they receive to provide high-quality care. The purpose of this study is to identify and analyse different cluste...
A cross-sectional design was applied. The data were collected in 2017 from three Finnish acute care hospitals with the Revised Humane Caring Scale (RHCS) as a paper questionnaire, including six backgr...
A total of 1810 patients participated in the study. Patient satisfaction was categorised into four groups: dissatisfied (n = 58), moderately dissatisfied (n = 249), moderately satisfied (n = 608), and...
The results mostly demonstrated high levels of patient satisfaction; however, the perceptions of minority populations of dissatisfied patients should be assessed to identify shortcomings in the care p...
Understanding the base pairing of an RNA sequence provides insight into its molecular structure. By mining suboptimal sampling data, RNAprofiling 1.0 identifies the dominant helices in low-energy seco...
In view of the problems of the traditional cluster analysis algorithm such as strong dependence on the initial cluster center, the traditional...
Geometric ability includes elements of identification, conceptualization, combination, drawing, and reasoning, and graphic perception is an important part of it. Kindergarten science education include...
Traditional texture cluster algorithms are frequently used in engineering; however, despite their widespread application, these algorithms continue to suffer from drawbacks including excessive complex...
Cancer has become a major health concern due to the increasing morbidity and mortality rates, and its negative social, economic consequences and the heavy financial burden incurred by cancer patients....
We conducted a cross-sectional survey of adult patients at Mohamed Sekkat and Sidi Othmane Hospitals in Casablanca, Morocco. Data collection was conducted by two trained interviewers who administered ...
The cluster-based analysis showed that participants in cluster 1 had the highest mean attitude score (13.9 ± 2.15) and percentage of individuals with a high level of knowledge (50.8%) whereas the lowe...
The findings showed that female individuals living in rural settings, belonging to an older age group, who were least likely to use health professionals as an information source had the lowest levels ...
Seizure clustering, is the most frequently reported adverse event in epilepsy monitoring unit (EMU) safety studies which, can also potentiate other adverse events, such as falls, status epilepticus, a...
A retrospective review of patients admitted to the EMU over a two-year period was completed. Data collected included patient demographics, types of epilepsy, seizure frequency, anti-seizure medication...
Two hundred seven patients were included in our study; of these, ninety patients experienced two or more seizures in a 24-hour period (24SC), and 68 patients experienced two or more seizures in a 4-ho...
Our data showed that long-acting ASMs can be protective against seizure clustering. Furthermore, patients with temporal lobe epilepsy, and those on increased numbers of ASMs, were more likely to exper...
Over the last decade, advances in understanding the pathophysiology, clinical presentation, systemic consequences and treatment responses in obstructive sleep apnea (OSA) have made individualised OSA ...
Patients diagnosed with OSA on level 1 polysomnography (PSG) were included. Clinical and co-morbidity profile, anthropometry and sleepiness scores were compiled. On PSG, apnea-hypopnea index, position...
One hundred patients (66 males) with a mean age of 49.5 ± 13.3 years were included. Snoring was reported by 94% subjects, and 50% were excessively sleepy. Two-thirds of subjects had co-morbidities, th...
This study revealed three OSA clusters with distinct demographic, anthropometric and PSG features. Further research with bigger sample size and additional parameters may pave the way for characterisin...
Previous studies suggested that distinct phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA; formerly known as Churg-Strauss syndrome) could be determined by the presence or absence of ...
This study used standardized data of 15 European centers for patients with EGPA fulfilling widely accepted classification criteria. We used multiple correspondence analysis, hierarchical cluster analy...
The analyses included 489 patients diagnosed between 1984 and 2015. ANCA were detected in 37.2% of patients, mostly perinuclear ANCA (85.4%) and/or antimyeloperoxidase (87%). Compared with ANCA-negati...
Although reinforcing the known association of ANCA status with clinical manifestations, cluster analysis does not support a complete separation of EGPA in ANCA-positive and -negative subsets. Collecti...
In the present study, we applied cluster analysis (CA) in SLE patients with joint involvement to identify which disease subset most commonly develops erosive damage....
We collected clinical and laboratory data of SLE patients with a clinical history of joint involvement (arthritis/arthralgia). Ultrasonographic assessment was performed at level of MCPs and PIPs joint...
CA included 112 SLE patients (M/F 6/106; median age 45 years, IQR 17; median disease duration 96 months, IQR 165). Arthritis was observed in 82 patients (73.2%) and inflammatory arthralgia in 30 (26.8...
The application of CA made it possible to better characterise SLE phenotype including erosive arthritis. In particular, feature-driven CA leads to the identification of a more aggressive disease, due ...